Skip to main content
SpringerLink
Log in

A Histopathological Contribution to Supratentorial Glioma Grading, Definition of Mixed Gliomas and Recognition of Low Grade Glioma With Rosenthal Fibers

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background Previous glioma studies have described separate grading systems for oligodendrogliomas and astrocytomas. Many of these gliomas contain mixtures of neoplastic astrocytes and oligodendrocytes. Prognosis may be related to the percentages of these neoplastic components. Previous survival/grading studies have been limited to histopathological features but have not evaluated the importance of percentages of neoplastic components. This study attempted to perceive the relative importance of percentages of neoplastic astrocytes and oligodendrocytes for definition of astroglial, oligodendroglial and mixed oligoastroglial tumors. After determination of these limits we explored the possibility to develop a grading system for common supratentorial gliomas based on reproducible histopathological features.

Methods A retrospective study was performed of 362 cases of unselected supratentorial glioma. One hundred and thirty-eight binary and nine continuous histopathological variables, amongst which percentages of neoplastic astrocytes and oligodendrocytes, were scored and related to survival. Only well reproducible histological features were accepted in Cox regression to define glioma grades.

Results and conclusions Supratentorial gliomas appeared to be composed of variable percentages of neoplastic oligodendrocytes and astrocytes, but this spectrum did not correspond to a continuous change in prognosis. Gliomas containing 30% or more neoplastic oligodendrocytes had a slightly better outcome (p < 0.0432) but higher percentages did not further improve prognosis. Percentages of neoplastic astrocytes were not correlated to survival. We therefore propose to designate gliomas containing 30% or more neoplastic oligodendrocytes as oligodendroglial tumors, and others as astroglial tumors. From a prognostic point of view there is no need to recognize mixedbreak oligoastrocytomas.

An interesting finding was the recognition of a low grade glioma group with Rosenthal fibers, which had the longest postoperative survival. Another prognosticator of interest concerns the mitotic rate as a continuous variable. Atypical mitoses indicated the worst survival, after necrosis. It was possible to develop a grading system for all supratentorial gliomas using six reproducible histological parameters: necrosis, atypical mitoses, the mitotic rate, endothelial proliferative activity, percentage of neoplastic oligodendrocytes and Rosenthal fibers. This resulted in four grades for astroglial tumors (p < 0.002) and three grades for oligodendroglial tumors (p < 0.008) which differed significantly within each group with respect to survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alvord EC Jr: Is necrosis helpful in the grading of gliomas? Editorial opinion. J Neuropathol Exp Neurol 51: 127-132, 1992

    Google Scholar 

  2. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous system 5th edn. Williams and Wilkins. In: Tumours of Central Neuroepithelial Origin. Baltimore 1989, pp 83-246

  3. Willis RA: Pathology of Tumours. Butterworth & Co., London, 1948, pp 802-823

    Google Scholar 

  4. Cooper ERA: The relation of oligocytes and astrocytes in cerebral tumours. J Pathol Bacteriol 41: 259-266, 1935

    Google Scholar 

  5. Bailey P, Cushing H: A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. JB Lippincott, Philadelphia, 1926

    Google Scholar 

  6. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW: Grading of oligodendrogliomas. Cancer 52: 2107-2104, 1983

    Google Scholar 

  7. Ravens JR, Adamkiewicz LL, Groff R: Cytology and cellular pathology of the oligodendrogliomas of the brain. J Neuropathol Exp Neurol 14: 142-184, 1955

    Google Scholar 

  8. Bruner JM: Neuropathology of malignant gliomas. Seminars in Oncology 21: 126-138, 1994

    Google Scholar 

  9. Wacker MR, Hoshino T, Ahn DK, Davis RL, Prados MD: The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J Neuro-Oncol 19: 113-122, 1994

    Google Scholar 

  10. Russell & Rubinstein's: Pathology of Tumors of the Nervous System, 6th edn. In: Bigner DD, McLendon RE, Bruner JM (eds). Epidemiology Mechanimsm of Altered Growth Control DNA Damage and Repair-Experimental Tumors Cellular Immunology-Molecular Immunology. Pathologic anatomy: Tumors of Central Neuroepithelial Origin, Vol I, Chapter 9, 1998, pp 307-571

  11. Burger PC, Scheithauer BW, Vogel FS: Surgical pathology of the nervous system and its coverings. Churchill Livingstone, New York, 1991, pp 193-437

    Google Scholar 

  12. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, 2nd edn. World Health Organization, Geneva: Springer-Verlag, Berlin, Heidelberg, New York, 1993, pp 11-30

    Google Scholar 

  13. Hart MN, Petito CK, Earle KM: Mixed Gliomas. Cancer 33: 134-140, 1974

    Google Scholar 

  14. Zülch KJ, Wechsler W: Pathology and classification of gliomas. Prog Neurol Surg 2: 1-84, 1968

    Google Scholar 

  15. Daumas-Duport C, Varlet P, Tucker M, Beuvon F, Cervera P, Chodkiewicz J: Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neuro-Oncol 34: 37-59, 1997

    Google Scholar 

  16. Daumas-Duport C, Tucker M, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz J: Oligodendrogliomas. Part II. A new grading system based on morphological and imaging criteria. J Neuro-Oncol 34: 61-78, 1997

    Google Scholar 

  17. Graham DI, Lantos PL: Greenfields Pathology, Tumours of the Nervous System, 6th edn., Vol II, Chapter 9, 1997, pp 583-636

  18. Daumas-Duport C, Scheithauer BW, O'Fallon J, Kelly P: Grading of astrocytomas: A simple and reproducible method. Cancer 62: 2152-2165, 1988

    Google Scholar 

  19. Eng LF, Rubinstein LJ: Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem 26: 513-522, 1978

    Google Scholar 

  20. Meulen van der JDM, Houthof HJ, Ebels EJ: Glial fibrillary acidic protein in human tumors. Neuropath Appl Neurobiol 4: 177-190, 1978

    Google Scholar 

  21. Schindler E, Gullotta F: Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumors. Virch Arch Path Anat 398: 263-275, 1982

    Google Scholar 

  22. Bignami A, Schoene WC: Glial fibrillary acid protein in human braintumors. In: DeLellis RA (ed). Diagnostic immunohistochemistry. Masson USA, New York, 1981, pp 213-225

  23. Dearmond SJ, Enf LF, Rubinstein LJ: The application of glial fibrillary acidic (GFA) protein immunohistochemistry in neuro-oncology. Pathol Res Pract 168: 374-394, 1980

    Google Scholar 

  24. Tascos NA, Parr J, Gonatas NK: Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum Pathol 13: 454-458, 1982

    Google Scholar 

  25. Herpers MJHM, Budka H: Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 64: 265-272, 1984

    Google Scholar 

  26. Schröder R: Die relative Häufigkeit atypischer mitosen in astrocytomen und glioblastomen Zentralbl Neurochir 24: 289-299, 1964

    Google Scholar 

  27. Radner H, Kleinert R, Vennigerholz F, Denk H: Peculiar changes in Rosenthal fibres in an atypical astrocytoma. Neuropathol Appl Neurobiol 16: 171-177, 1990

    Google Scholar 

  28. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33: 159-174, 1977

    Google Scholar 

  29. Cohen J: Acoefficient of agreement for nominal scales. Educ Psychol Measurement 20: 37-46, 1960

    Google Scholar 

  30. Segal MR: Regression trees for censored data. Biometrics 44: 35-47, 1988

    Google Scholar 

  31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958

    Google Scholar 

  32. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: analysis and examples. Br J Cancer 35: 1-39, 1977

    Google Scholar 

  33. Cox DR: Regression models and lifetables. J R Stat Soc 34(series B): 187-220, 1972

    Google Scholar 

  34. Anderson RL, Bancroft TA: Statistical Theory in Research. McGraw Hill, New York, 1952

    Google Scholar 

  35. Tarone RE: Amodified Bonferroni method for discrete data. Biometrics 46: 515-522, 1990

    Google Scholar 

  36. Demetris AJ, Belle SH, Hart J, Lewin K, Ludwig J, Snover DC, Tillery GW, Detre K: Intraobserver and interobserver variation in the histopathological assessment of liver allowgraft rejection. Hepatol 14: 751-755, 1991

    Google Scholar 

  37. Ringertz N: Grading of gliomas. Acta Pathol Microbiol Scand 27: 51-46, 1950

    Google Scholar 

  38. Kernohan JW, Sayre GP: Tumours of the central nervous system. In: Atlas of Tumor Pathology. Sect X. Fascicles 35 and 37. Washington DC: Armed Forces Institute of Pathology, 1952, pp 17-42

    Google Scholar 

  39. Gillis FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET: Histologic feature reliability in childhood neural tumors. J Neuropathol Exp Neurol 53: 559-571, 1994

    Google Scholar 

  40. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381-1393, 1997

    Google Scholar 

  41. Krouwer HG, Davis RL, Silver P, Prados M: Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74: 399-406, 1991

    Google Scholar 

  42. Burger PC, Vollmer RT: Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 46: 1179-1186, 1980

    Google Scholar 

  43. Margetts JC, Kalyan-Raman UP: Giant-celled glioblastoma of brain. Cancer 63: 524-531, 1989

    Google Scholar 

  44. Brooks WH, Markesbery WR, Gupta GD, Roszman TL: Relationship of lymphocyte invasion and survival of brain tumor patients. Annals of Neurology 4: 219-224, 1978

    Google Scholar 

  45. Schiffer D, Dutto A, Cavalla P, Bosone I, Chiò A, Villani R, Bellotti: Prognostic factors in oligodendroglioma. Can J Neurol Sci 24: 313-319, 1997

    Google Scholar 

  46. Krouwer HGJ, Duinen SG, Kamphorst W, van der Valk P, Algra A: Oligoastrocytomas: a clinicopathological study of 52 cases. J Neuro-Oncol 33: 223-238, 1997

    Google Scholar 

  47. Mørk SJ, Halvorsen TB, Lindegaard K-F, Eide GE: Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 45: 65-78, 1986

    Google Scholar 

  48. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC, Bullard DE: Clinicopathologic correlations in the oligodendrogliomas. Cancer 59: 1345-1352, 1987

    Google Scholar 

  49. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV-chemotherapy. J Neurosurg 76: 741-745, 1992

    Google Scholar 

  50. Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurg 32: 365-371, 1993

    Google Scholar 

  51. Wallner KE, Gonzales M, Sheline GE: Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68: 684-688, 1988

    Google Scholar 

  52. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH: Mixed oligo-astrocytomas: a survival and prognostic factor analysis. Neurosurg 34: 577-582, 1994

    Google Scholar 

  53. Rubinstein LJ: Morphological problems of brain tumors with mixed cell populations. Acta Neurochir Suppl X (Wien): 141-165, 1964

  54. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, Macdonald D, Cairncross G: Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294-1301, 1997

    Google Scholar 

  55. Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC: Histopathology, classification, and grading of gliomas. Glia 15: 211-221, 1995

    Google Scholar 

  56. Davis RL: Grading of gliomas. In: Fields WS (ed). Primary Brain Tumors. A Review of Histologic classification. New York, Springer-Verlag, 1989, pp 150-158

    Google Scholar 

  57. Coons SW, Pearl DK: Mitosis identification in diffuse gliomas. Implications for tumor grading. Cancer 82: 1550-1555, 1998

    Google Scholar 

  58. ten Kate TK, Beliën JAM, Smeulders AWM, Baak JPA: Method for counting mitoses by image processing in Feulgen stained breast cancer sections. Cytometry 14: 241-250, 1993

    Google Scholar 

  59. Beliën JAM, Baak JPA, van Diest PJ, Ginkel AHM: Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution. Cytometry 28: 135-140, 1997; Cytometry 29: 189, 1997

    Google Scholar 

  60. Sobel EI, Gilles FH, Tavaré CJ, Leviton A, Hedley-Whyte ET: Prognosis for children with supratentorial neuroglial tumors. Pediatric Pathol Lab Med 17: 755-767, 1997

    Google Scholar 

  61. McLendon RE, Enterline DS, Tien RB, Thorstad WL, Bruner JM. In: Bigner DD, Mclendon RE, Bruner JM (eds). Russel & Rubinsteins. Pathology of Tumors of the Nervous System. 6th edn. Tumors of Central Neuroepithelial Origin, Vol 1, Chapter 9, 1998

  62. Lopes BS, Vandenberg SR, Scheithauer BW: The pathology of oligodendrogliomas. In: Appuzo MLS (ed). Benign Cerebral Glioma. Vol 1. AANS 1995, pp 83-94

  63. Mørk SJ, Lindegaard K-F, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, Harvei S, Ganz J: Oligodendroglioma: incidence and biological behaviour in a defined population. J Neurosurg 63: 881-889, 1985

    Google Scholar 

  64. Bruner JM. Oligodendroglioma: diagnosis and prognosis. Semin Diagn Pathol 4: 251-261, 1987

    Google Scholar 

  65. Burger PC, Scheithauer BW: Oligodendroglial neoplasms. In: AFIP Atlas of tumor pathology. Series 3. Fascicle X. Armed Forces Institute of Pathology. Washington DC, 1994, pp 107-120

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Free University Hospital, Amsterdam, The Netherlands

    J.M.J. Cillekens, J.A.M. Beliën, P. van der Valk, P.J. van Diest & W. Kamphorst

  2. Department of Clinical Physics and Informatics, Free University Hospital, Amsterdam, The Netherlands

    T.J.C. Faes

  3. Department of Pathology, Department of Clinical Physics and Informatics, Department of Radiotherapy, Free University Hospital, Amsterdam, The Netherlands

    M.A.M. Broeckaert

  4. Department of Radiotherapy, Free University Hospital, Amsterdam, The Netherlands

    J.H. Kralendonk

Authors
  1. J.M.J. Cillekens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.A.M. Beliën
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. van der Valk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T.J.C. Faes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P.J. van Diest
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M.A.M. Broeckaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J.H. Kralendonk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. Kamphorst
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cillekens, J., Beliën, J., van der Valk, P. et al. A Histopathological Contribution to Supratentorial Glioma Grading, Definition of Mixed Gliomas and Recognition of Low Grade Glioma With Rosenthal Fibers. J Neurooncol 46, 23–43 (2000). https://doi.org/10.1023/A:1006496328729

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006496328729

Search

Navigation